Zarafonetis CJ, Dabich L, Skovronski JJ, et al. Retrospective studies in scleroderma: skin response to potassium para-aminobenzoate therapy.
Clin Exp Rheumatol
. 1988;6:261 - 268.
Zarafonetis CJ, Dabich L, Negri D, et al. Retrospective studies in scleroderma: effect of potassium para-aminobenzoate on survival.
J Clin Epidemiol
. 1988;41:193 - 205.
Clegg DO, Reading JC, Mayes MD. Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.
. 1994;21:105 - 110.
Hasche-Klunder R. Treatment of Peyronie's disease with para-aminobenzoacidic potassium [in German; English abstract].
1978;17:224 - 247.
Carson CC. Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective?
. 1997;3:135 - 139.
Ludwig G. Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis).
. 1991;47:236 - 239.
Sieve BF. The clinical effects of a new B complex factor, para-aminobenzoic acid, on pigmentation and fertility.
South Med Surg
. 1942;104:135 - 139.
8Physicians' Desk Reference
. Oradell, NJ: Medical Economics Co; 1989.
Kantor GR, Ratz JL. Liver toxicity from potassium para-aminobenzoate.
J Am Acad Dermatol
. 1985;13:671 - 672.
Hughes CG. Oral PABA and vitiligo [letter].
J Am Acad Dermatol
Degowin RL, Eppes RB, Carson PE, et al. The effects of diaphenylsulfone (DDS) against chloroquine-resistant
Plasmodium falciparum.Bull World Health Organ.
1966;34:671 - 681.
Vinnicombe HG, Derrick JP. Dihydropteroate synthase from
characterization of substrate binding order and sulfonamide inhibition.
Biochem Biophys Res Commun.
1999;258:752 - 757.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.
Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.